AVITA MEDICAL (AVMXY) earnings

AVMXY earnings moved a median of +4.51% by the close. Quarterly and annual AVMXY reports and results, each read against the price at its own news timestamp. Back to the AVMXY overview →

27 measured AVMXY earnings events.

Where these AVMXY earnings landedvs 26 measured AVMXY earnings reactions
AVMXY earningsMiddle 50% · -1.51% to +12.21%Zero: 0.00%Median: +4.51%Median +4.51%-20.00%0+20.00%
Middle 50% of AVMXY earnings reactions-1.51% to +12.21%
Median reaction (to close)+4.51%
Measured reactions26
Point-in-time · zero look-ahead

Half of the 26 AVMXY earnings events with a measured close landed between -1.51% and +12.21%; 69% closed up.

DateHeadlineEvent5-minTo close
AVITA Medical Reports Second Quarter Results, Raises 2026 Revenue Guidance, and Expects Fourth Quarter Cash Flow BreakevenPress release+8.35%+29.72%
Form 10-Q AVITA Medical, Inc. For: Jun 30SEC filing · Form 10-Q+8.35%+29.72%
AVITA Medical to Announce Second Quarter 2026 Financial ResultsPress release+0.74%+16.79%
AVITA Medical Reports First Quarter 2026 Financial ResultsPress release+12.88%-2.15%
Form 10-Q AVITA Medical, Inc. For: Mar 31SEC filing · Form 10-Q+12.88%-2.15%
AVITA Medical to Announce First Quarter 2026 Financial ResultsPress release-2.07%+2.53%
Form 10-K AVITA Medical, Inc. For: Dec 31SEC filing · Form 10-K+2.73%+13.66%
AVITA® Medical Reports Third Quarter 2025 Financial ResultsPress release+0.00%+11.87%
Form 10-Q AVITA Medical, Inc. For: Sep 30SEC filing · Form 10-Q+0.00%+11.87%
AVITA Medical to Announce Third Quarter 2025 Financial ResultsPress release+0.27%-1.87%
Form 10-Q AVITA Medical, Inc. For: Jun 30SEC filing · Form 10-Q+6.97%+13.94%
AVITA Medical Reports Second Quarter 2025 Financial Results, Updates Full-Year Guidance, and Highlights Continued Clinical InnovationPress release+6.97%+13.94%
AVITA Medical to Announce Second Quarter 2025 Financial ResultsPress release+0.93%—
AVITA Medical Reports First Quarter 2025 Financial ResultsPress release-3.18%-3.86%
Form 10-Q AVITA Medical, Inc. For: Mar 31SEC filing · Form 10-Q-3.18%-3.86%
AVITA Medical to Announce First Quarter 2025 Financial ResultsPress release+0.78%+1.11%
Form 10-K AVITA Medical, Inc. For: Dec 31SEC filing · Form 10-K+2.29%+6.55%
Form 10-Q AVITA Medical, Inc. For: Sep 30SEC filing · Form 10-Q-3.42%-0.42%
AVITA Medical to Announce Third Quarter 2024 Financial ResultsPress release-0.25%+4.56%
Form 10-Q AVITA Medical, Inc. For: Jun 30SEC filing · Form 10-Q+1.41%+12.32%
AVITA Medical to Announce Second Quarter 2024 Financial ResultsPress release+0.11%+4.46%
Form 10-Q AVITA Medical, Inc. For: Mar 31SEC filing · Form 10-Q+0.63%+9.82%
AVITA Medical to Announce First Quarter 2024 Financial ResultsPress release+1.37%+2.54%
AVITA Medical Updates Expected First Quarter 2024 RevenuePress release-9.53%-15.72%
Form 10-K AVITA Medical, Inc. For: Dec 31SEC filing · Form 10-K+1.28%+9.54%
Form 10-Q AVITA Medical, Inc. For: Sep 30SEC filing · Form 10-Q-6.67%-5.92%
AVITA Medical to Announce Third Quarter 2023 Financial ResultsPress release+0.00%+1.09%
That’s how AVMXY usually reacts to earnings — get an email when it moves on news →
Keep exploring

More AVMXY: analyst actions → · SEC filings → · AVMXY overview →

Other Healthcare names and their earnings

TickerEventsMedian 30-min% positive
NanoVibronix, Inc. (NAOV)161-0.40%39%
Zomedica Corp. Common Shares (ZOM)161+0.08%53%
Adaptimmune Therapeutics plc - American Depositary Shares (ADAP)159-1.17%27%
DURECT Corporation (DRRX)159+0.03%51%

Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its earnings — that is what the link opens.